tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Paradigm Biopharmaceuticals Announces Change in Substantial Shareholder Status
Company AnnouncementsParadigm Biopharmaceuticals Announces Change in Substantial Shareholder Status
4d ago
Paradigm Biopharmaceuticals Expands Global Phase 3 Trial with New Sites
PremiumCompany Announcements
Paradigm Biopharmaceuticals Expands Global Phase 3 Trial with New Sites
4d ago
Paradigm Biopharmaceuticals Issues 3 Million Unlisted Options
PremiumCompany Announcements
Paradigm Biopharmaceuticals Issues 3 Million Unlisted Options
9d ago
Paradigm Biopharmaceuticals Announces 2025 Annual General Meeting Details
PremiumCompany Announcements
Paradigm Biopharmaceuticals Announces 2025 Annual General Meeting Details
27d ago
Paradigm Biopharmaceuticals Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Paradigm Biopharmaceuticals Expands Market Presence with New Securities Quotation
1M ago
Paradigm Biopharmaceuticals Advances Phase 3 iPPS Trial for Knee Osteoarthritis
PremiumCompany AnnouncementsParadigm Biopharmaceuticals Advances Phase 3 iPPS Trial for Knee Osteoarthritis
2M ago
Paradigm Biopharmaceuticals Secures Shareholder Approval for Strategic Financial Moves
Premium
Company Announcements
Paradigm Biopharmaceuticals Secures Shareholder Approval for Strategic Financial Moves
2M ago
Paradigm Biopharmaceuticals Sets AGM Date and Director Nomination Deadline
Premium
Company Announcements
Paradigm Biopharmaceuticals Sets AGM Date and Director Nomination Deadline
2M ago
Paradigm Biopharmaceuticals Launches Unmarketable Parcel Sale Facility
PremiumCompany Announcements
Paradigm Biopharmaceuticals Launches Unmarketable Parcel Sale Facility
2M ago
Paradigm Biopharmaceuticals Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Paradigm Biopharmaceuticals Expands Market Presence with New Securities Quotation
2M ago
Paradigm Biopharmaceuticals to Present Osteoarthritis Treatment Advances at Healthcare Conference
PremiumCompany Announcements
Paradigm Biopharmaceuticals to Present Osteoarthritis Treatment Advances at Healthcare Conference
2M ago
Paradigm Biopharmaceuticals Releases 2025 Corporate Governance Statement
PremiumCompany Announcements
Paradigm Biopharmaceuticals Releases 2025 Corporate Governance Statement
3M ago
Paradigm Biopharmaceuticals Advances Osteoarthritis Treatment with Strategic Trials and Acquisitions
PremiumCompany AnnouncementsParadigm Biopharmaceuticals Advances Osteoarthritis Treatment with Strategic Trials and Acquisitions
3M ago
Paradigm Biopharmaceuticals Launches InvestorHub Amidst Pivotal Clinical Trial Phase
Premium
Company Announcements
Paradigm Biopharmaceuticals Launches InvestorHub Amidst Pivotal Clinical Trial Phase
3M ago
Paradigm Biopharmaceuticals to Quote New Securities on ASX
Premium
Company Announcements
Paradigm Biopharmaceuticals to Quote New Securities on ASX
3M ago
Paradigm Biopharmaceuticals Announces Extraordinary General Meeting
PremiumCompany Announcements
Paradigm Biopharmaceuticals Announces Extraordinary General Meeting
3M ago
Paradigm Biopharmaceuticals Updates on Phase 3 iPPS Trial
PremiumCompany Announcements
Paradigm Biopharmaceuticals Updates on Phase 3 iPPS Trial
4M ago
Paradigm Biopharmaceuticals Advances Phase 3 Osteoarthritis Trial and Expands Pipeline
PremiumCompany Announcements
Paradigm Biopharmaceuticals Advances Phase 3 Osteoarthritis Trial and Expands Pipeline
4M ago
Paradigm Biopharmaceuticals Announces Phase 3 Trial Update Webinar
PremiumCompany Announcements
Paradigm Biopharmaceuticals Announces Phase 3 Trial Update Webinar
4M ago
Paradigm Biopharmaceuticals Expands ASX Quotation with New Securities
PremiumCompany AnnouncementsParadigm Biopharmaceuticals Expands ASX Quotation with New Securities
4M ago
Paradigm Biopharmaceuticals Secures US$27 Million in Convertible Notes Agreement
Premium
Company Announcements
Paradigm Biopharmaceuticals Secures US$27 Million in Convertible Notes Agreement
4M ago
Paradigm Biopharmaceuticals Issues 7 Million Convertible Notes
Premium
Company Announcements
Paradigm Biopharmaceuticals Issues 7 Million Convertible Notes
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >